Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
lercanidipine hydrochloride
Mylan Health Pty Ltd
Lercanidipine hydrochloride
Registered
LERCANIDIPINE SANDOZ _Lercanidipine hydrochloride_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about Lercanidipine Sandoz. It does not contain all the available information. It does not replace seeking advice from your doctor or pharmacist. PLEASE READ THIS LEAFLET BEFORE YOU START TAKING LERCANIDIPINE SANDOZ. If you are helping someone else take Lercanidipine Sandoz, please read this leaflet before you give the first dose. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Lercanidipine Sandoz against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT LERCANIDIPINE SANDOZ IS USED FOR The name of your medicine is Lercanidipine Sandoz, which is also known as lercanidipine. Lercanidipine Sandoz belongs to a group of medicines called calcium channel blockers (of the dihydropyridine group). Lercanidipine Sandoz lowers high blood pressure, which doctors call hypertension. It works by relaxing some of the blood vessels in the body and reducing resistance to the flow of blood through the blood vessels. Everyone has blood pressure. This pressure helps get your blood all around your body. Your blood pressure may be different at different times of the day, depending on how busy or worried you are. You have hypertension (high blood pressure) when your blood pressure stays higher than is needed, even when you are calm and relaxed. There are usually no symptoms of hypertension. The only way of knowing that you have hypertension is to have your blood pressure checked on a regular basis. If high blood pressure is not treated it can lead to serious health problems. You may feel fine and have no symptoms, but eventually hypertension can cause stroke, heart disease and kidney failure. Lercanidipine Sandoz helps lower your blood pressure. Lercanidipine Sandoz cannot be obtained Read the complete document
AUSTRALIAN PRODUCT INFORMATION LERCANIDIPINE SANDOZ _Lercanidipine hydrochloride tablets _ 1 NAME OF THE MEDICINE Lercanidipine hydrochloride 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Lercanidipine hydrochloride is a microcrystalline, odourless, citrine powder. Each Lercanidipine Sandoz 10 mg tablet contains 9.4 mg of lercanidipine (present as lercanidipine hydrochloride 10 mg) as the active ingredient. Each Lercanidipine Sandoz 20 mg tablet contains 18.8 mg of lercanidipine (present as lercanidipine hydrochloride 20 mg) as the active ingredient. Excipients with known effect: Lercanidipine Sandoz also contains lactose, see SECTION 4.4 - SPECIAL WARNINGS AND PRECAUTIONS FOR USE . For the full list of excipients, see SECTION 6.1 - LIST OF EXCIPIENTS . 3 PHARMACEUTICAL FORM Lercanidipine Sandoz 10 mg tablet is available as a yellow, round, scored, film-coated tablet. Lercanidipine Sandoz 20 mg tablet is available as a pink, circular, biconvex, film-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lercanidipine Sandoz is indicated for the treatment of hypertension. 4.2 DOSE AND METHOD OF ADMINISTRATION The recommended dose is 10 mg once daily, at least 15 minutes before a meal. The dose may be increased to 20 mg once daily depending on the individual response. Dose titration should be gradual, as it may take about 2 weeks for the maximal antihypertensive effect to be apparent. Titration may proceed more rapidly, however, if clinically warranted, provided the patient is assessed frequently. Since it is unlikely that increasing the dose beyond 20 mg will further improve the efficacy, and may be associated with side effects, doses above 20 mg are not recommended. Some individuals not adequately controlled on a single antihypertensive agent may benefit from the addition of lercanidipine at the same doses used in monotherapy to the existing regimen with a beta-blocker, a diuretic or an ACE inhibitor. Use in elderly, children, hepatic and renal impairment: see SECTION 4.4 - SPECIAL WARNINGS AND PRECAUTIO Read the complete document